Anti-Interleukin-12 Antibody Treatment for Crohn Disease: Potential Risk of Invasive Disease Due to Mycobacteria and Salmonellae Infection

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2005-05, Vol.40 (9), p.1381-1382
Main Authors: MacLennan, Calman, Lammas, David A., Kumararatne, Dinakantha S.
Format: Article
Language:English
Subjects:
Antibodies
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Correspondence
Crohn disease
Crohn Disease - drug therapy
Deficiency diseases
Disease risk
Fungal diseases
Fungal infections
Humans
Infections
Interleukin-12 - immunology
Mycobacterium Infections - complications
Salmonella Infections - complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-36b8c13e94f7b96bfb1af8b67d0d74e989de15515ef34cf299e7c90ca1e03c603
cites cdi_FETCH-LOGICAL-c421t-36b8c13e94f7b96bfb1af8b67d0d74e989de15515ef34cf299e7c90ca1e03c603
container_end_page 1382
container_issue 9
container_start_page 1381
container_title Clinical infectious diseases
container_volume 40
creator MacLennan, Calman
Lammas, David A.
Kumararatne, Dinakantha S.
description
doi_str_mv 10.1086/429511
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_67732480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4484185</jstor_id><oup_id>10.1086/429511</oup_id><sourcerecordid>4484185</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-36b8c13e94f7b96bfb1af8b67d0d74e989de15515ef34cf299e7c90ca1e03c603</originalsourceid><addsrcrecordid>eNp1kcFu1DAURSMEoqXAFyBkWLAL-CV2YrOrZko7UisQLRJiEznOs_BMYg-2UzG_0K8mowythMTqWe8eX1_rZtlLoO-BiuoDKyQHeJQdAy_rvOISHk9nykXORCmOsmcxrikFEJQ_zY6Ai4JTXhxnd6cu2XzlEoYex411ORRkv2t9tyM3AVUa0CVifCCL4H86srQRVcSP5ItPk2JVT77auCHekJW7VdHe4l-GLEckyZOrnfat0tMbVhHlOnKt-sE77HuF0yWDOlnvnmdPjOojvjjMk-zbp7ObxUV--fl8tTi9zDUrIOVl1QoNJUpm6lZWrWlBGdFWdUe7mqEUskPgHDiakmlTSIm1llQrQFrqipYn2bvZdxv8rxFjagYb9T6MQz_GpqrrsmBiD779B1z7MbgpW1OAlExwKB7cdPAxBjTNNthBhV0DtNlX08zVTODrg9vYDtg9YIcuJuDNDPhx-3-TVzOzjsmHe4oxwUDwSc5n2caEv-9lFTbTr8qaNxfffzT1FVwv6XLRnJd_AL9hq0k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219948512</pqid></control><display><type>article</type><title>Anti-Interleukin-12 Antibody Treatment for Crohn Disease: Potential Risk of Invasive Disease Due to Mycobacteria and Salmonellae Infection</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford Journals Online</source><creator>MacLennan, Calman ; Lammas, David A. ; Kumararatne, Dinakantha S.</creator><creatorcontrib>MacLennan, Calman ; Lammas, David A. ; Kumararatne, Dinakantha S.</creatorcontrib><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/429511</identifier><identifier>PMID: 15825052</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Antibodies ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - therapeutic use ; Correspondence ; Crohn disease ; Crohn Disease - drug therapy ; Deficiency diseases ; Disease risk ; Fungal diseases ; Fungal infections ; Humans ; Infections ; Interleukin-12 - immunology ; Mycobacterium Infections - complications ; Salmonella Infections - complications</subject><ispartof>Clinical infectious diseases, 2005-05, Vol.40 (9), p.1381-1382</ispartof><rights>Copyright 2005 The Infectious Diseases Society of America</rights><rights>2005 by the Infectious Diseases Society of America 2005</rights><rights>Copyright University of Chicago, acting through its Press May 1, 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-36b8c13e94f7b96bfb1af8b67d0d74e989de15515ef34cf299e7c90ca1e03c603</citedby><cites>FETCH-LOGICAL-c421t-36b8c13e94f7b96bfb1af8b67d0d74e989de15515ef34cf299e7c90ca1e03c603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4484185$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4484185$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15825052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MacLennan, Calman</creatorcontrib><creatorcontrib>Lammas, David A.</creatorcontrib><creatorcontrib>Kumararatne, Dinakantha S.</creatorcontrib><title>Anti-Interleukin-12 Antibody Treatment for Crohn Disease: Potential Risk of Invasive Disease Due to Mycobacteria and Salmonellae Infection</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><subject>Antibodies</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Correspondence</subject><subject>Crohn disease</subject><subject>Crohn Disease - drug therapy</subject><subject>Deficiency diseases</subject><subject>Disease risk</subject><subject>Fungal diseases</subject><subject>Fungal infections</subject><subject>Humans</subject><subject>Infections</subject><subject>Interleukin-12 - immunology</subject><subject>Mycobacterium Infections - complications</subject><subject>Salmonella Infections - complications</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp1kcFu1DAURSMEoqXAFyBkWLAL-CV2YrOrZko7UisQLRJiEznOs_BMYg-2UzG_0K8mowythMTqWe8eX1_rZtlLoO-BiuoDKyQHeJQdAy_rvOISHk9nykXORCmOsmcxrikFEJQ_zY6Ai4JTXhxnd6cu2XzlEoYex411ORRkv2t9tyM3AVUa0CVifCCL4H86srQRVcSP5ItPk2JVT77auCHekJW7VdHe4l-GLEckyZOrnfat0tMbVhHlOnKt-sE77HuF0yWDOlnvnmdPjOojvjjMk-zbp7ObxUV--fl8tTi9zDUrIOVl1QoNJUpm6lZWrWlBGdFWdUe7mqEUskPgHDiakmlTSIm1llQrQFrqipYn2bvZdxv8rxFjagYb9T6MQz_GpqrrsmBiD779B1z7MbgpW1OAlExwKB7cdPAxBjTNNthBhV0DtNlX08zVTODrg9vYDtg9YIcuJuDNDPhx-3-TVzOzjsmHe4oxwUDwSc5n2caEv-9lFTbTr8qaNxfffzT1FVwv6XLRnJd_AL9hq0k</recordid><startdate>20050501</startdate><enddate>20050501</enddate><creator>MacLennan, Calman</creator><creator>Lammas, David A.</creator><creator>Kumararatne, Dinakantha S.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050501</creationdate><title>Anti-Interleukin-12 Antibody Treatment for Crohn Disease: Potential Risk of Invasive Disease Due to Mycobacteria and Salmonellae Infection</title><author>MacLennan, Calman ; Lammas, David A. ; Kumararatne, Dinakantha S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-36b8c13e94f7b96bfb1af8b67d0d74e989de15515ef34cf299e7c90ca1e03c603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Antibodies</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Correspondence</topic><topic>Crohn disease</topic><topic>Crohn Disease - drug therapy</topic><topic>Deficiency diseases</topic><topic>Disease risk</topic><topic>Fungal diseases</topic><topic>Fungal infections</topic><topic>Humans</topic><topic>Infections</topic><topic>Interleukin-12 - immunology</topic><topic>Mycobacterium Infections - complications</topic><topic>Salmonella Infections - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MacLennan, Calman</creatorcontrib><creatorcontrib>Lammas, David A.</creatorcontrib><creatorcontrib>Kumararatne, Dinakantha S.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MacLennan, Calman</au><au>Lammas, David A.</au><au>Kumararatne, Dinakantha S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Interleukin-12 Antibody Treatment for Crohn Disease: Potential Risk of Invasive Disease Due to Mycobacteria and Salmonellae Infection</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2005-05-01</date><risdate>2005</risdate><volume>40</volume><issue>9</issue><spage>1381</spage><epage>1382</epage><pages>1381-1382</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>15825052</pmid><doi>10.1086/429511</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2005-05, Vol.40 (9), p.1381-1382
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_67732480
source JSTOR Archival Journals and Primary Sources Collection; Oxford Journals Online
subjects Antibodies
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Correspondence
Crohn disease
Crohn Disease - drug therapy
Deficiency diseases
Disease risk
Fungal diseases
Fungal infections
Humans
Infections
Interleukin-12 - immunology
Mycobacterium Infections - complications
Salmonella Infections - complications
title Anti-Interleukin-12 Antibody Treatment for Crohn Disease: Potential Risk of Invasive Disease Due to Mycobacteria and Salmonellae Infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A01%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Interleukin-12%20Antibody%20Treatment%20for%20Crohn%20Disease:%20Potential%20Risk%20of%20Invasive%20Disease%20Due%20to%20Mycobacteria%20and%20Salmonellae%20Infection&rft.jtitle=Clinical%20infectious%20diseases&rft.au=MacLennan,%20Calman&rft.date=2005-05-01&rft.volume=40&rft.issue=9&rft.spage=1381&rft.epage=1382&rft.pages=1381-1382&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/429511&rft_dat=%3Cjstor_proqu%3E4484185%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-36b8c13e94f7b96bfb1af8b67d0d74e989de15515ef34cf299e7c90ca1e03c603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=219948512&rft_id=info:pmid/15825052&rft_jstor_id=4484185&rft_oup_id=10.1086/429511&rfr_iscdi=true